Fantastic! It is very exciting, isn't it! We are that much closer to hearing that approval has been received, that they have provided everything the FDA needs for HemaXellerate to be classified as an Orphan Drug and that the trial period will be a short one. Given that they have plenty of data and research to prove its safety, it will not take long at all for marketability. And they are ironing out the creases for MIN.

THIS IS WONDERFUL!. I don't know how people can't see that.